Credit Suisse’s Procept Biorobotics PRCT Stock Holding History

Credit Suisse’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$2.74M	Buy	55,407 +1,441	+3%	+$68.6K	﹤0.01%	1653
2023 Q4	$2.26M	Buy	53,966 +8,683	+19%	+$296K	﹤0.01%	1807
2023 Q3	$1.49M	Sell	45,283 -417	-0.9%	-$14.2K	﹤0.01%	2015
2023 Q2	$1.62M	Buy	45,700 +29,605	+184%	+$979K	﹤0.01%	2071
2023 Q1	$457K	Buy	16,095 +8,670	+117%	+$306K	﹤0.01%	2796
2022 Q4	$308K	Sell	7,425 -169	-2%	-$7.26K	﹤0.01%	3020
2022 Q3	$314K	Buy	7,594 +430	+6%	+$17.2K	﹤0.01%	3061
2022 Q2	$234K	Buy	+7,164	New	+$261K	﹤0.01%	3271

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Credit Suisse's PRCT Position: Q1 2024 in Review

Credit Suisse increased its Procept Biorobotics (PRCT) stake by 2.7% in Q1 2024, buying an estimated $68.6K and bringing the position to 55,407 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1653.

Credit Suisse first reported a position in PRCT in Q2 2022 and has held it in 8 quarters since. 162 funds tracked by Wall St. Rank hold PRCT as of Q1 2024.

Credit Suisse held 55,407 shares of Procept Biorobotics worth $2.74M as of Q1 2024.
Credit Suisse bought 1,441 Procept Biorobotics shares in Q1 2024, an estimated $68.6K.
Procept Biorobotics made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1653 holding.
Credit Suisse first reported a position in Procept Biorobotics in Q2 2022 and has held it in 8 quarters since.
162 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.